These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9106232)

  • 1. Cytokines and acute neurodegeneration.
    Rothwell NJ
    Mol Psychiatry; 1997 Mar; 2(2):120-1. PubMed ID: 9106232
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications.
    Rothwell N; Allan S; Toulmond S
    J Clin Invest; 1997 Dec; 100(11):2648-52. PubMed ID: 9389726
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of glutamic acid in the pathogenesis of stroke and the development of neuroprotective drugs.
    Evans SM; Addae JI
    West Indian Med J; 1995 Dec; 44(4):119-23. PubMed ID: 8838047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Watch for ICE in neurodegeneration.
    Vasilakos J; Shivers B
    Mol Psychiatry; 1996 Mar; 1(1):72-6. PubMed ID: 9118318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine: a prototherapeutic concept in neurodegeneration.
    von Lubitz DK; Carter MF; Beenhakker M; Lin RC; Jacobson KA
    Ann N Y Acad Sci; 1995 Sep; 765():163-78; discussion 196-7. PubMed ID: 7486604
    [No Abstract]   [Full Text] [Related]  

  • 6. Involvement of cytokines in acute neurodegeneration in the CNS.
    Rothwell NJ; Relton JK
    Neurosci Biobehav Rev; 1993; 17(2):217-27. PubMed ID: 8515904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical localization of interleukin-1beta, interleukin-1 receptor antagonist and interleukin-1beta converting enzyme/caspase-1 in the rat brain after peripheral administration of kainic acid.
    Eriksson C; Van Dam AM; Lucassen PJ; Bol JG; Winblad B; Schultzberg M
    Neuroscience; 1999; 93(3):915-30. PubMed ID: 10473257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1 beta attenuates excitatory amino acid-induced neurodegeneration in vitro: involvement of nerve growth factor.
    Strijbos PJ; Rothwell NJ
    J Neurosci; 1995 May; 15(5 Pt 1):3468-74. PubMed ID: 7538561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of the interleukin-1 receptor antagonist (IL-1ra) on experimental allergic encephalomyelitis in rats.
    Martin D; Near SL
    J Neuroimmunol; 1995 Sep; 61(2):241-5. PubMed ID: 7593560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokines in neurodegeneration and repair.
    Rothwell NJ; Strijbos PJ
    Int J Dev Neurosci; 1995; 13(3-4):179-85. PubMed ID: 7572274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain protection.
    Cohadon F
    Adv Tech Stand Neurosurg; 1994; 21():77-152. PubMed ID: 7872978
    [No Abstract]   [Full Text] [Related]  

  • 12. Central nervous system cytokines and their relevance for neurotoxicity and apoptosis.
    Licinio J
    J Neural Transm Suppl; 1997; 49():169-75. PubMed ID: 9266426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Future treatment of stroke. Brain damage in stroke can be reduced by drugs].
    Siesjö BK
    Lakartidningen; 1993 Sep; 90(36):2958, 2962-4. PubMed ID: 8366724
    [No Abstract]   [Full Text] [Related]  

  • 14. Contribution of the ICE family to neurodegeneration.
    Shivers BD; Boxer PA; Keane KM; Kupina NC; Lynch T; Schielke GP; Vartanian MG; Vasilakos JP
    Ann N Y Acad Sci; 1998 May; 840():59-64. PubMed ID: 9629237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist.
    Dinarello CA
    Int Rev Immunol; 1998; 16(5-6):457-99. PubMed ID: 9646173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neuroprotection in stroke. A critical overview].
    Block F; Schwarz M
    Nervenarzt; 1999 Feb; 70(2):101-10. PubMed ID: 10098144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage.
    Hara H; Friedlander RM; Gagliardini V; Ayata C; Fink K; Huang Z; Shimizu-Sasamata M; Yuan J; Moskowitz MA
    Proc Natl Acad Sci U S A; 1997 Mar; 94(5):2007-12. PubMed ID: 9050895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration.
    Eriksson C; Tehranian R; Iverfeldt K; Winblad B; Schultzberg M
    J Neurosci Res; 2000 Apr; 60(2):266-79. PubMed ID: 10740232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against ischaemia: the basis of acute stroke therapy.
    Harrison MJ
    Curr Opin Neurol Neurosurg; 1992 Feb; 5(1):33-8. PubMed ID: 1623235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-1 and its inhibitors: implications for disease biology and therapy.
    Estrov Z; Kurzrock R; Talpaz M
    Cancer Treat Res; 1995; 80():51-82. PubMed ID: 8821574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.